LIVER FIBROSES
Clinical trials for LIVER FIBROSES explained in plain language.
Never miss a new study
Get alerted when new LIVER FIBROSES trials appear
Sign up with your email to follow new studies for LIVER FIBROSES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo test could spot liver damage before It's too late
Diagnosis Recruiting nowThis study aims to improve early diagnosis of liver fibrosis (scarring) by combining standard blood tests with new markers, genetic analysis, and gut bacteria profiles. Researchers will enroll 1,200 adults referred to a liver clinic. The goal is to identify advanced fibrosis soon…
Matched conditions: LIVER FIBROSES
Sponsor: Manchester University NHS Foundation Trust • Aim: Diagnosis
Last updated May 16, 2026 23:51 UTC
-
Cholesterol drug could slash liver cancer risk in scarred livers
Prevention Recruiting nowThis study tests whether atorvastatin, a widely used cholesterol medication, can reduce the risk of developing liver cancer in people with advanced liver fibrosis or cirrhosis. About 60 adults at high risk will receive either atorvastatin or a placebo for up to 48 weeks. The main…
Matched conditions: LIVER FIBROSES
Phase: PHASE2 • Sponsor: Raymond Chung • Aim: Prevention
Last updated May 15, 2026 11:55 UTC